Gulf Pharmaceutical Industries PSC 2022 SR
The report highlights Julphar's 2022 ESG performance, marking its third consecutive year of reporting. Key financial achievements include a 40.3% increase in revenue and a 24% growth in production volume, driven by the launch of Strategy 2030. Environmentally, the company achieved a 1.2% reduction in total greenhouse gas emissions and a 3.6% decrease in water consumption. Socially, Julphar increased its female workforce by 6.7% and provided over 30,000 hours of professional development training. The report also details strategic partnerships and the launch of 13 new products to enhance healthcare access.
Company: Gulf Pharmaceutical Industries PSC
Sector: Manufacturing
Country: United Arab Emirates
Year: 2022
Type: SR
Pages: 26
Back to company
Gulf Pharmaceutical Industries PSC
ESG Report
The report highlights Julphar's 2022 ESG performance, marking its third consecutive year of reporting. Key financial achievements include a 40.3% increase in revenue and a 24% growth in production volume, driven by the launch of Strategy 2030. Environmentally, the company achieved a 1.2% reduction in total greenhouse gas emissions and a 3.6% decrease in water consumption. Socially, Julphar increased its female workforce by 6.7% and provided over 30,000 hours of professional development training. The report also details strategic partnerships and the launch of 13 new products to enhance healthcare access.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Jan 1, 2022 - Dec 31, 2022
Fiscal Year
2022
Type
Sustainability Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Other Standards
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Water Consumption
Total Waste
Women on Board
Workplace Fatalities
Employees